Why the study?
Does hydrocortisone increase platelet activation markers in healthy subjects?
Does hydrocortisone increase platelet activation markers in healthy subjects?
Answers are grounded in this paper and cite their sources.
Short-term induction of hypercortisolism in healthy volunteers does not significantly increase major platelet activation markers, suggesting other mechanisms may link depression to cardiac risk.
INTRODUCTION: Hypercortisolism, as seen in the majority of patients with major depression, may be associated with the generation of platelets that show signs of increased activation. METHODS: Within a study using a placebo-controlled double-blind cross-over design, 9 healthy subjects ingested hydrocortisone (daily dose = 40 mg) or placebo on 7 consecutive days. At the end of each study segment, we analyzed platelets for the surface activation markers P-selectin, glycoprotein 53, and PAC-1 and measured platelet-leucocyte aggregates in serum. RESULTS: Hydrocortisone ingestion was not associated with changes in the platelet activation markers P-selectin and PAC-1 or the number of circulating platelet-leucocyte aggregates but with a trend (p = 0.056) toward higher expression of glycoprotein 53 on the platelet surface. CONCLUSIONS: Induction of hypercortisolism in healthy volunteers was not associated with a major increase in platelet activation markers.
No takes yet. Share an insight, caveat, or question.
Baranyai et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: